TrialNature2026
Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma.
Jiawei Lv et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
TrialNature2026
Jiawei Lv et al.PubMed ↗Publisher ↗
No numbers read from the abstract.